Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 9;115(3):341-342.
doi: 10.1093/jnci/djad005.

RE: Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program

Affiliations
Comment

RE: Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program

Christopher A Haiman et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment in

  • Response to Haiman, Kote-Jarai, Darst et al.
    Seibert TM, Pagadala MS, Lynch J, Karunamuni R, Carter H, Rose BS, Hauger RL. Seibert TM, et al. J Natl Cancer Inst. 2023 Mar 9;115(3):343-344. doi: 10.1093/jnci/djad006. J Natl Cancer Inst. 2023. PMID: 36629482 Free PMC article. No abstract available.

Comment on

References

    1. Conti DV, Darst BF, Moss LC, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53(1):65-75. - PMC - PubMed
    1. Chen F, Darst BF, Madduri RK, et al. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations. Elife. 2022;11:e78304. - PMC - PubMed
    1. Plym A, Penney KL, Kalia S, et al. Evaluation of a multiethnic polygenic risk score model for prostate cancer. J Natl Cancer Inst. 2022;114(5):771-774. doi: 10.1093/jnci/djab058. - DOI - PMC - PubMed
    1. Pagadala MS, Lynch J, Karunamuni R, et al. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program [published online ahead of print October 28, 2022]. J Natl Cancer Inst. 2023;115(3):190-199. doi: 10.1093/jnci/djac199. - DOI - PMC - PubMed